Equity · Healthcare
CRNX
NASDAQCrinetics Pharmaceuticals (CRNX)
The line runs $83.66 on 23 July through $85 on 31 August, on a scale from $83.5 to $85.5. Days the market did not trade hold the previous close, flat.
as of Aug 31, 2026
Crinetics Pharmaceuticals (CRNX) insider trades
In the 90 days to 21 Oct 2026, no Crinetics Pharmaceuticals insider bought or sold shares on the open market; all 13 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 13 compensation filings in this window. The figures above count all of them.
Crinetics Pharmaceuticals (CRNX) reported financials
SEC EDGARCrinetics Pharmaceuticals reported revenue of $7.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$465.3M.
Crinetics Pharmaceuticals (CRNX) earnings
Crinetics Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$1.14; no next date is announced in SEC filings yet.
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
Crinetics Pharmaceuticals (CRNX) institutional holders (13F)
SEC EDGAR7 of the 45 institutional funds we track reported a Crinetics Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined $170.4M; the latest of those filings landed 02 Sep 2026.
Congressional trades in Crinetics Pharmaceuticals (CRNX)
House disclosuresThe most recent congressional trade disclosed in Crinetics Pharmaceuticals is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 03 Mar 2026.
Crinetics Pharmaceuticals (CRNX): frequently asked questions
Have Crinetics Pharmaceuticals insiders bought or sold shares recently?
In the 90 days to 21 Oct 2026, no Crinetics Pharmaceuticals insider bought or sold shares on the open market; all 13 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
How many institutions hold Crinetics Pharmaceuticals?
7 of the 45 institutional funds we track reported a Crinetics Pharmaceuticals position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.
When did Crinetics Pharmaceuticals last report earnings?
Crinetics Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$1.14; no next date is announced in SEC filings yet.
What exchange is Crinetics Pharmaceuticals listed on?
Crinetics Pharmaceuticals trades on NASDAQ under the ticker CRNX.
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
- SEC EDGARSEC EDGAR 13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARValuation computed from SEC EDGAR filings